Lifevantage (NASDAQ:LFVN) Share Price Crosses Above Two Hundred Day Moving Average - Here's What Happened

Key Points

• Lifevantage shares rose above their 200-day moving average on Friday, trading as high as $6.34 before last changing hands at $6.20. The stock’s 200-day average was $5.72.
• Analyst sentiment remains cautious: Lake Street Capital downgraded LFVN to Hold and set a $5.00 target, while the consensus rating is also Hold with an average target price of $5.00.
• The company recently raised its quarterly dividend to $0.05 per share from $0.04, implying a 3.2% annualized yield. However, its latest earnings missed estimates, with EPS of $0.12 versus $0.16 expected and revenue below forecasts.

Lifevantage Corporation (NASDAQ:LFVN - Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $5.72 and traded as high as $6.34. Lifevantage shares last traded at $6.20, with a volume of 89,958 shares.

Analysts Set New Price Targets

A number of brokerages have issued reports on LFVN. Lake Street Capital cut Lifevantage from a "buy" rating to a "hold" rating and set a $5.00 target price for the company. in a report on Thursday, May 7th. Weiss Ratings raised Lifevantage from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday, May 26th. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $5.00.

Lifevantage Stock Performance

The company has a fifty day simple moving average of $6.78 and a 200 day simple moving average of $5.72. The stock has a market capitalization of $78.24 million, a price-to-earnings ratio of 13.78 and a beta of 0.73.

Lifevantage (NASDAQ:LFVN - Get Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.04). The company had revenue of $43.72 million during the quarter, compared to analyst estimates of $47.77 million. Lifevantage had a net margin of 2.94% and a return on equity of 23.89%. As a group, equities analysts predict that Lifevantage Corporation will post 0.6 earnings per share for the current fiscal year.

Lifevantage Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 3.2%. The ex-dividend date was Monday, June 1st. This is a positive change from Lifevantage's previous quarterly dividend of $0.04. Lifevantage's dividend payout ratio (DPR) is 44.44%.

Institutional Investors Weigh In On Lifevantage

A number of institutional investors have recently modified their holdings of LFVN. DGS Capital Management LLC bought a new position in Lifevantage during the first quarter worth $44,000. Hsbc Holdings PLC bought a new stake in Lifevantage during the first quarter valued at $51,000. JPMorgan Chase & Co. grew its holdings in Lifevantage by 870.2% during the 2nd quarter. JPMorgan Chase & Co. now owns 5,016 shares of the company's stock worth $66,000 after acquiring an additional 4,499 shares during the period. Franklin Resources Inc. acquired a new stake in Lifevantage during the 4th quarter worth about $74,000. Finally, Aristides Capital LLC bought a new position in shares of Lifevantage in the 4th quarter worth about $76,000. 35.32% of the stock is owned by institutional investors.

About Lifevantage

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company's flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.